ID

31575

Description

Green Tea or Water in Treating Patients With Prostate Cancer Undergoing Surgery; ODM derived from: https://clinicaltrials.gov/show/NCT00685516

Lien

https://clinicaltrials.gov/show/NCT00685516

Mots-clés

Versions (1)
  1. 06/09/2018 06/09/2018 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

6 septembre 2018

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Prostate Cancer NCT00685516

Anglais

Eligibility Prostate Cancer NCT00685516

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
subject consents to participate in the trial.
Description

Informed Consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
subject is 40-75 years of age and has a diagnosis of adenocarcinoma of the prostate.
Description

Age | Adenocarcinoma of prostate

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2]
C0007112
scheduled to undergo radical prostatectomy.
Description

Radical prostatectomy Scheduled

Type de données

boolean

Alias
UMLS CUI [1,1]
C0194810
UMLS CUI [1,2]
C0205539
the subject agrees to stop consumption of tea or tea-containing products throughout the entire intervention period except for the tea provided during study intervention.
Description

Tea Consumption Discontinuation | Tea Product Consumption Discontinuation

Type de données

boolean

Alias
UMLS CUI [1,1]
C0039400
UMLS CUI [1,2]
C0009830
UMLS CUI [1,3]
C1444662
UMLS CUI [2,1]
C0039400
UMLS CUI [2,2]
C1514468
UMLS CUI [2,3]
C0009830
UMLS CUI [2,4]
C1444662
the subject agrees to stop consumption of dietary or vitamin supplements (e.g., lycopene, vitamin e, selenium, genistein) or herbal supplements (e.g., saw palmetto, pc-spes)
Description

Dietary Supplements Consumption Discontinuation | Vitamin supplement Consumption Discontinuation | Lycopene | Vitamin E | Selenium | Genistein | Herbal Supplements Consumption Discontinuation | Saw palmetto extract | PC-SPES

Type de données

boolean

Alias
UMLS CUI [1,1]
C0242295
UMLS CUI [1,2]
C0009830
UMLS CUI [1,3]
C1444662
UMLS CUI [2,1]
C0681579
UMLS CUI [2,2]
C0009830
UMLS CUI [2,3]
C1444662
UMLS CUI [3]
C0065331
UMLS CUI [4]
C0042874
UMLS CUI [5]
C0036581
UMLS CUI [6]
C0061202
UMLS CUI [7,1]
C1504473
UMLS CUI [7,2]
C0009830
UMLS CUI [7,3]
C1444662
UMLS CUI [8]
C0771607
UMLS CUI [9]
C0756934
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
history of hepatitis or liver dysfunction
Description

Hepatitis | Liver Dysfunction

Type de données

boolean

Alias
UMLS CUI [1]
C0019158
UMLS CUI [2]
C0086565
ongoing alcohol abuse
Description

Alcohol abuse

Type de données

boolean

Alias
UMLS CUI [1]
C0085762
significant medical or psychiatric conditions that would make the patient a poor protocol candidate
Description

Medical condition Study Subject Participation Status Poor | Mental condition Study Subject Participation Status Poor

Type de données

boolean

Alias
UMLS CUI [1,1]
C3843040
UMLS CUI [1,2]
C2348568
UMLS CUI [1,3]
C2700379
UMLS CUI [2,1]
C3840291
UMLS CUI [2,2]
C2348568
UMLS CUI [2,3]
C2700379
prior sensitivity or allergic reaction to tea, tea products, or tea supplements
Description

Hypersensitivity Tea | Hypersensitivity Tea product | Hypersensitivity Tea Supplements | Allergic Reaction Tea | Allergic Reaction Tea product | Allergic Reaction Tea Supplements

Type de données

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0039400
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0039400
UMLS CUI [2,3]
C1514468
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C0039400
UMLS CUI [3,3]
C0242295
UMLS CUI [4,1]
C1527304
UMLS CUI [4,2]
C0039400
UMLS CUI [5,1]
C1527304
UMLS CUI [5,2]
C0039400
UMLS CUI [5,3]
C1514468
UMLS CUI [6,1]
C1527304
UMLS CUI [6,2]
C0039400
UMLS CUI [6,3]
C0242295
allergy or sensitivity to multiple food items or nutritional supplements
Description

ALLERGY TO MULTIPLE FOOD | Hypersensitivity Dietary Supplements

Type de données

boolean

Alias
UMLS CUI [1]
C0744084
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0242295
concurrent luteinizing hormone-releasing hormone agonists, androgen receptor blocking agents, or finasteride
Description

Luteinizing Hormone-releasing Hormone Agonist | Androgen Receptor Antagonists | Finasteride

Type de données

boolean

Alias
UMLS CUI [1]
C1518041
UMLS CUI [2]
C2936804
UMLS CUI [3]
C0060389
prior bilateral orchiectomy
Description

Bilateral orchiectomy

Type de données

boolean

Alias
UMLS CUI [1]
C0007347
Retour au début de la page

Similar models

Eligibility Prostate Cancer NCT00685516

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Informed Consent
Item
subject consents to participate in the trial.
boolean
C0021430 (UMLS CUI [1])
Age | Adenocarcinoma of prostate
Item
subject is 40-75 years of age and has a diagnosis of adenocarcinoma of the prostate.
boolean
C0001779 (UMLS CUI [1])
C0007112 (UMLS CUI [2])
Radical prostatectomy Scheduled
Item
scheduled to undergo radical prostatectomy.
boolean
C0194810 (UMLS CUI [1,1])
C0205539 (UMLS CUI [1,2])
Tea Consumption Discontinuation | Tea Product Consumption Discontinuation
Item
the subject agrees to stop consumption of tea or tea-containing products throughout the entire intervention period except for the tea provided during study intervention.
boolean
C0039400 (UMLS CUI [1,1])
C0009830 (UMLS CUI [1,2])
C1444662 (UMLS CUI [1,3])
C0039400 (UMLS CUI [2,1])
C1514468 (UMLS CUI [2,2])
C0009830 (UMLS CUI [2,3])
C1444662 (UMLS CUI [2,4])
Dietary Supplements Consumption Discontinuation | Vitamin supplement Consumption Discontinuation | Lycopene | Vitamin E | Selenium | Genistein | Herbal Supplements Consumption Discontinuation | Saw palmetto extract | PC-SPES
Item
the subject agrees to stop consumption of dietary or vitamin supplements (e.g., lycopene, vitamin e, selenium, genistein) or herbal supplements (e.g., saw palmetto, pc-spes)
boolean
C0242295 (UMLS CUI [1,1])
C0009830 (UMLS CUI [1,2])
C1444662 (UMLS CUI [1,3])
C0681579 (UMLS CUI [2,1])
C0009830 (UMLS CUI [2,2])
C1444662 (UMLS CUI [2,3])
C0065331 (UMLS CUI [3])
C0042874 (UMLS CUI [4])
C0036581 (UMLS CUI [5])
C0061202 (UMLS CUI [6])
C1504473 (UMLS CUI [7,1])
C0009830 (UMLS CUI [7,2])
C1444662 (UMLS CUI [7,3])
C0771607 (UMLS CUI [8])
C0756934 (UMLS CUI [9])
Item Group
C0680251 (UMLS CUI)
Hepatitis | Liver Dysfunction
Item
history of hepatitis or liver dysfunction
boolean
C0019158 (UMLS CUI [1])
C0086565 (UMLS CUI [2])
Alcohol abuse
Item
ongoing alcohol abuse
boolean
C0085762 (UMLS CUI [1])
Medical condition Study Subject Participation Status Poor | Mental condition Study Subject Participation Status Poor
Item
significant medical or psychiatric conditions that would make the patient a poor protocol candidate
boolean
C3843040 (UMLS CUI [1,1])
C2348568 (UMLS CUI [1,2])
C2700379 (UMLS CUI [1,3])
C3840291 (UMLS CUI [2,1])
C2348568 (UMLS CUI [2,2])
C2700379 (UMLS CUI [2,3])
Hypersensitivity Tea | Hypersensitivity Tea product | Hypersensitivity Tea Supplements | Allergic Reaction Tea | Allergic Reaction Tea product | Allergic Reaction Tea Supplements
Item
prior sensitivity or allergic reaction to tea, tea products, or tea supplements
boolean
C0020517 (UMLS CUI [1,1])
C0039400 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0039400 (UMLS CUI [2,2])
C1514468 (UMLS CUI [2,3])
C0020517 (UMLS CUI [3,1])
C0039400 (UMLS CUI [3,2])
C0242295 (UMLS CUI [3,3])
C1527304 (UMLS CUI [4,1])
C0039400 (UMLS CUI [4,2])
C1527304 (UMLS CUI [5,1])
C0039400 (UMLS CUI [5,2])
C1514468 (UMLS CUI [5,3])
C1527304 (UMLS CUI [6,1])
C0039400 (UMLS CUI [6,2])
C0242295 (UMLS CUI [6,3])
ALLERGY TO MULTIPLE FOOD | Hypersensitivity Dietary Supplements
Item
allergy or sensitivity to multiple food items or nutritional supplements
boolean
C0744084 (UMLS CUI [1])
C0020517 (UMLS CUI [2,1])
C0242295 (UMLS CUI [2,2])
Luteinizing Hormone-releasing Hormone Agonist | Androgen Receptor Antagonists | Finasteride
Item
concurrent luteinizing hormone-releasing hormone agonists, androgen receptor blocking agents, or finasteride
boolean
C1518041 (UMLS CUI [1])
C2936804 (UMLS CUI [2])
C0060389 (UMLS CUI [3])
Bilateral orchiectomy
Item
prior bilateral orchiectomy
boolean
C0007347 (UMLS CUI [1])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial